Concepedia

Michael J. Tolentino

MJ

Statistics

Publications

32

Citations

4.6K

H-Index

27

Active since

1993

Affiliations

Massachusetts Eye and Ear Infirmary(Current)

University of Pennsylvania

Harvard University

Penn Presbyterian Medical Center

Boston Children's Hospital

Michael J. Tolentino is an author at Massachusetts Eye and Ear Infirmary specializing in ophthalmology, medicine, and vascular biology.

ORCID

Top concepts

Publications per year

1993–2023

32

Publications

32

Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate

Michael J. Tolentino, Joan W. Miller, Evangelos S. Gragoudas et al. · Ophthalmology · 1996 · 519 citations

, , +8

Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.

Samuel J. Reich, Joshua Fosnot, A. Kuroki et al. · PubMed · 2003 · 439 citations

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.

Manabu Kuroki, Emile E. Voest, Shiro Amano et al. · Journal of Clinical Investigation · 1996 · 420 citations · Full text

, , +19

Advanced glycation end products increase retinal vascular endothelial growth factor expression.

Ming Y. Lu, Manabu Kuroki, Seiji Amano et al. · Journal of Clinical Investigation · 1998 · 419 citations · Full text

, , +15

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.

Shiro Amano, Richard M. Rohan, Manabu Kuroki et al. · PubMed · 1998 · 338 citations

1–5 of 32